Sangamo Therapeutics (NASDAQ:SGMO) PT Lowered to $3.00 at HC Wainwright
Sangamo Therapeutics (NASDAQ:SGMO – Free Report) had its target price trimmed by HC Wainwright from $5.00 to $3.00 in a report published on Monday, Benzinga reports. The brokerage currently has a buy rating on the biopharmaceutical company’s stock. HC Wainwright also issued estimates for Sangamo Therapeutics’ Q4 2023 earnings at ($0.24) EPS, FY2023 earnings at […]
More Stories
Flagship Harbor Advisors LLC Boosts Stake in Everest Group, Ltd. (NYSE:EG)
Flagship Harbor Advisors LLC raised its stake in shares of Everest Group, Ltd. (NYSE:EG – Free Report) by 3.7% during...
Janney Montgomery Scott LLC Has $2.20 Million Stock Position in Global X S&P 500 Covered Call ETF (NYSEARCA:XYLD)
Janney Montgomery Scott LLC lowered its stake in Global X S&P 500 Covered Call ETF (NYSEARCA:XYLD – Free Report) by...
Oppenheimer Asset Management Inc. Buys 11,731 Shares of e.l.f. Beauty (NYSE:ELF)
Oppenheimer Asset Management Inc. lifted its position in e.l.f. Beauty (NYSE:ELF – Free Report) by 36.4% during the 1st quarter,...
Global X Artificial Intelligence & Technology ETF (NASDAQ:AIQ) Shares Acquired by Janney Montgomery Scott LLC
Janney Montgomery Scott LLC lifted its stake in shares of Global X Artificial Intelligence & Technology ETF (NASDAQ:AIQ – Free...
Oppenheimer & Co. Inc. Buys 61,953 Shares of Robinhood Markets, Inc. (NASDAQ:HOOD)
Oppenheimer & Co. Inc. raised its stake in shares of Robinhood Markets, Inc. (NASDAQ:HOOD – Free Report) by 237.2% during...
Paycom Software, Inc. (NYSE:PAYC) Shares Acquired by Kentucky Retirement Systems
Kentucky Retirement Systems lifted its stake in shares of Paycom Software, Inc. (NYSE:PAYC – Free Report) by 3.9% in the...